There was ample evidence that TICs in TME, including CD8 positive T cells and NK cells, were not only related to the prognosis of BLCA, but also a promising biomarker prediction tool for treatment response (12). The gene discussed is CD8A; the disease is bladder transitional cell carcinoma.